Jie Jin
- Molecular Biology
- Oncology top 10%
- Hematology top 5%
- Pathology and Forensic Medicine top 10%
- Immunology
- Co-authors
- Junmin LiLiuping ZhangGenbao ShaoAihua GongJianda HuJianrong SangHongyan TongJian‐Qing Mi
- Topics
- Multiple Myeloma Research and Treatments (12 papers)Lymphoma Diagnosis and Treatment (11 papers)CAR-T cell therapy research (9 papers)
- Cited by
- HematologyOncologyGenetics
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Jie Jin
55 papers receiving 901 citations
Peers
Comparison fields: 5 of 116
- Molecular Biology 381
- Oncology 341
- Hematology 290
- Pathology and Forensic Medicine 142
- Immunology 113
Countries citing papers authored by Jie Jin
This map shows the geographic impact of Jie Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Jin more than expected).
Fields of papers citing papers by Jie Jin
This network shows the impact of papers produced by Jie Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Jin. The network helps show where Jie Jin may publish in the future.
Co-authorship network of co-authors of Jie Jin
This figure shows the co-authorship network connecting the top 25 collaborators of Jie Jin. A scholar is included among the top collaborators of Jie Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Jin. Jie Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 14 | |
| 8 | 4 | |
| 9 | 1 | |
| 10 | 3 | |
| 11 | 25 | |
| 12 | 7 | |
| 13 | 23 | |
| 14 | 109 | |
| 15 | 15 | |
| 16 | 35 | |
| 17 | 40 | |
| 18 | 17 | |
| 19 | 37 | |
| 20 | 14 |
About Jie Jin
Jie Jin is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine, having authored 64 papers that have together received 913 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (12 papers), Lymphoma Diagnosis and Treatment (11 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Hematology (290 citations), Oncology (341 citations) and Genetics (94 citations). Jie Jin has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Junmin Li, Liuping Zhang, Genbao Shao, Aihua Gong, Jianda Hu, Jianrong Sang, Hongyan Tong, Jian‐Qing Mi, Ziqiang Yu and Ming Hou. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.